BLUE BIRD CORP. news, videos and press releases - Page 4
For more news please use our advanced search feature.
BLUE BIRD CORP. - More news...
BLUE BIRD CORP. - More news...
- Blue Bird Reports Fiscal Year 2023 Second Quarter Results; Turnaround Ahead of Schedule; Raises Guidance for the Year
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE
- Blue Bird to Report Fiscal 2023 Second Quarter Results on May 11, 2023
- bluebird bio Reports First Quarter 2023 Financial Results and Highlights Operational Progress
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE
- bluebird bio Announces First Quarter 2023 Earnings Date and Upcoming Investor Events
- Blue Bird Delivers Largest Electric School Bus Fleet in its History to Broward County Public Schools in Florida
- Boston Public Schools Puts First 20 Blue Bird Electric Buses in Operation
- bluebird bio Submits Biologics License Application (BLA) to FDA for lovotibeglogene autotemcel (lovo-cel) for Patients with Sickle Cell Disease (SCD) 12 years and Older with a History of Vaso-Occlusive Events
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE
- Blue Bird Appoints Simon Newman to Board of Directors
- bluebird bio Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Operational Progress
- Glancy Prongay & Murray LLP Announces Investigation of Blue Bird Corporation (BLBD) (f/k/a Hennessy Capital Acquisition Corp.)
- Blue Bird Announces Participation in the 35th Annual Roth Conference
- Blue Bird Reports Fiscal Year 2023 First Quarter Results; Record First Quarter Revenues & EV Sales; Raises Guidance for the Year
- Blue Bird to Report Fiscal Year 2023 First Quarter Results on February 8, 2023
- Blue Bird Welcomes New Dealership to Serve South Carolina
- bluebird bio, Inc. Announces Pricing of $120 Million Public Offering of Common Stock
- bluebird bio, Inc. Announces Proposed Public Offering of Common Stock
- bluebird bio Provides Update on Commercial Launch Progress, Program Milestones and 2023 Financial Outlook Ahead of Company Presentation at 41st Annual J.P. Morgan Healthcare Conference
- bluebird bio Sells Second Priority Review Voucher for $95 Million
- bluebird bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
- bluebird bio Appoints Joseph Vittiglio, JD, as Chief Business and Legal Officer
- FDA Lifts Partial Clinical Hold for bluebird bio’s Sickle Cell Disease (SCD) Studies for Patients Under the Age of 18
- Dearborn Public Schools Hailed as Blue Bird’s First Electric Bus Customer in Michigan
- Blue Bird Reports Fiscal 2022 Fourth Quarter and Full Year Results; Record EV Sales and Backlog; Positioned for a Strong Recovery in Fiscal 2023
- New Data from bluebird bio’s Gene Therapies for Transfusion-Dependent Beta-Thalassemia and Sickle Cell Disease Presented at 64th ASH Annual Meeting
- Blue Bird Teams Up with Highland Electric Fleets to Provide 12 Electric School Buses to Illinois School District
- bluebird bio Sells Priority Review Voucher for $102 Million
- Blue Bird Corporation Announces Amendment and Extension of Credit Facility
